Veterinary Medicines

Albiotic intramammær opløsning 10+33 mg/ml

Authorised
  • Neomycin
  • Lincomycin
Download as PDF

Product identification

Medicine name:
Albiotic intramammær opløsning 10+33 mg/ml
Albiotic 10+33 mg/ml intramammær opløsning
Active substance:
  • Neomycin
  • Lincomycin
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Neomycin
    100.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Lincomycin
    330.00
    milligram(s)
    /
    10.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary solution
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RG01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pfizer Manufacturing Belgium
  • Biovet J.S.C.
  • Zoetis Belgium
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 19240
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."